Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
Variants in other genes such as CDKL5 and FOXG1 are usually associated with individuals who manifest distinct phenotypes that may overlap with RTT.
|
25424712 |
2015 |
Malignant tumor of cervix
|
0.010 |
Biomarker
|
disease |
BEFREE |
Upregulated miR-200b in cervical cancer was proven to show positive regulation on cervical cancer development by directly targeting FoxG1.
|
27044840 |
2016 |
Cervix carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Upregulated miR-200b in cervical cancer was proven to show positive regulation on cervical cancer development by directly targeting FoxG1.
|
27044840 |
2016 |
cervical cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Upregulated miR-200b in cervical cancer was proven to show positive regulation on cervical cancer development by directly targeting FoxG1.
|
27044840 |
2016 |
Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
Under the OS point of view FOXG1-related RTT appears to be distinct from the MeCP2/CDKL5, suggesting a distinct mechanism involved in its pathogenesis.
|
21276437 |
2011 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Typical RTT is caused by de novo mutations of the gene MECP2 (OMIM*300005), and atypical forms of RTT can be caused by mutations of the CDKL5 (OMIM*300203) and FOXG1 (OMIM*164874) genes.
|
31206249 |
2019 |
Glioblastoma Multiforme
|
0.050 |
Biomarker
|
disease |
BEFREE |
To our knowledge, our data provide the first comprehensive clinical evidence that FOXA2, FOXN2, FOXN3 and FOXG1 are promising biomarkers of GBM and warrant further investigation.
|
25977169 |
2016 |
Neurodevelopmental Disorders
|
0.350 |
Biomarker
|
group |
BEFREE |
To assess the pattern of disorder-related missense mutations of NDD-related FOX genes, we manually curated de novo and inherited missense or inframeshift variants within FOXP1, FOXP2, and FOXG1 that co-segregated with phenotypes in NDDs.All variants were annotated by ANNOVAR.
|
31199603 |
2019 |
Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
Thus, we hypothesize that FOXG1 might be a new candidate gene in the etiology of LGS and suggest screening for this gene in cases of LGS with concomitant microcephaly and clinical features overlapping with Rett syndrome.
|
25266269 |
2014 |
Microcephaly
|
0.500 |
Biomarker
|
disease |
BEFREE |
Thus, we hypothesize that FOXG1 might be a new candidate gene in the etiology of LGS and suggest screening for this gene in cases of LGS with concomitant microcephaly and clinical features overlapping with Rett syndrome.
|
25266269 |
2014 |
Lennox-Gastaut syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, we hypothesize that FOXG1 might be a new candidate gene in the etiology of LGS and suggest screening for this gene in cases of LGS with concomitant microcephaly and clinical features overlapping with Rett syndrome.
|
25266269 |
2014 |
Glioblastoma Multiforme
|
0.050 |
Biomarker
|
disease |
BEFREE |
Thus, FOXG1 and SOX2 operate in complementary but distinct roles to fuel unconstrained self-renewal in GBM stem cells via transcriptional control of core cell cycle and epigenetic regulators.
|
28465359 |
2017 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
They further suggest that an abnormal sizing of the dendritic tree of neocortical projection neurons may occur in West and Rett syndrome patients with anomalous FOXG1 allele dosages and contribute to their neurolopathological profiles.
|
29385539 |
2019 |
Glioblastoma Multiforme
|
0.050 |
Biomarker
|
disease |
BEFREE |
These results provide previously unavailable insight into the transcriptional programs underlying the tumour-promoting functions of FOXG1:TLE1 in GBM.
|
29316219 |
2018 |
Glioblastoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
These results provide previously unavailable insight into the transcriptional programs underlying the tumour-promoting functions of FOXG1:TLE1 in GBM.
|
29316219 |
2018 |
Seizures
|
0.450 |
GeneticVariation
|
phenotype |
BEFREE |
These findings will improve our understanding of the postnatal development of interneurons and help to elucidate the mechanisms underlying seizure in patients carrying Foxg1 mutations.
|
29912324 |
2019 |
Epilepsies, Partial
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings suggest a central AKT-FOXG1-reelin signaling pathway in FMCD and support pathway inhibitors as potential treatments or therapies for some forms of focal epilepsy.
|
26523971 |
2015 |
Malformations of Cortical Development
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings suggest a central AKT-FOXG1-reelin signaling pathway in FMCD and support pathway inhibitors as potential treatments or therapies for some forms of focal epilepsy.
|
26523971 |
2015 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
These cases confirm the involvement of FOXG1 in the molecular etiology of the congenital variant of RTT and show the characteristic features of FOXG1-related disorder.
|
22129046 |
2012 |
FOXG1 syndrome
|
0.790 |
CausalMutation
|
disease |
CLINVAR |
The usefulness of whole-exome sequencing in routine clinical practice.
|
24901346 |
2014 |
Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
The systematic screening of Rett syndrome (RTT) patients for pathogenetic sequence variations has focused on three genes that have been associated with RTT or related clinical phenotypes, namely MECP2, CDKL5, and FOXG1.
|
22383159 |
2012 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
The results show that FOXG1 plays a key role in mediating cancer cell metastasis through the Wnt/β-catenin pathway in HCC cells and predicts HCC prognosis after surgery.
|
31771611 |
2019 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
The results show that FOXG1 plays a key role in mediating cancer cell metastasis through the Wnt/β-catenin pathway in HCC cells and predicts HCC prognosis after surgery.
|
31771611 |
2019 |
West Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
The results of the analyses of our patient provide further evidence that not only duplication but also a small increase in the dosage of FOXG1 could cause infantile spasms.
|
21910242 |
2011 |
Infantile Spasm
|
0.020 |
Biomarker
|
disease |
BEFREE |
The results of the analyses of our patient provide further evidence that not only duplication but also a small increase in the dosage of FOXG1 could cause infantile spasms.
|
21910242 |
2011 |